CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
2 hedge funds and large institutions have $51K invested in Loncar China BioPharma ETF in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$38K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$13K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $38K | +$38K | +2,000 | New |
|
|
2
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $13K | +$13K | +652 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$10K | -436 | Closed |
|